Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
130M
-
Number of holders
-
194
-
Total shares
-
55.7M
-
Shares change
-
+88.7K
-
Total reported value, excl. options
-
$3.74B
-
Value change
-
+$8.75M
-
Put/Call ratio
-
2.18
-
Number of buys
-
111
-
Number of sells
-
-76
-
Price
-
$67.14
Significant Holders of ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) as of Q1 2014
212 filings reported holding ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock as of Q1 2014.
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) has 194 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.7M shares
of 130M outstanding shares and own 42.79% of the company stock.
Largest 10 shareholders include FMR LLC (9.59M shares), WELLINGTON MANAGEMENT CO LLP (8.04M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.59M shares), VANGUARD GROUP INC (2.68M shares), FRANKLIN RESOURCES INC (2.6M shares), BlackRock Fund Advisors (2.31M shares), GILDER GAGNON HOWE & CO LLC (1.92M shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (1.67M shares), BlackRock Institutional Trust Company, N.A. (1.52M shares), and State Street Corp (1.43M shares).
This table shows the top 194 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.